Novo Nordisk

Mixed options sentiment in Novo Nordisk (NVO), with shares up 4c, or 0.1%, near $45.80. Options volume relatively light with 69k contracts traded and calls lead...

Advertisement What recent performance signals for Omeros (OMER) Without a single defining headline driving trading, Omeros (OMER) has still drawn attention af...

Key Points Investors have placed a high valuation on Eli Lilly because they believe GLP-1 drugs represent a massive opportunity. Eli Lilly is growing quickly...

Shares of Novo Nordisk (NVO) and Eli Lilly & Co. (LLY), two of the world’s largest drugmakers, rose slightly on Wednesday after data showed strong demand for th...

Amazon Pharmacy (AMZN) is expanding access to Novo Nordisk’s (NVO) Ozempic pill, the only FDA-approved oral GLP-1 medication to treat type 2 diabetes. Amazon Ph...

U.S. pharma giant Eli Lilly (LLY) has pumped another $4.5 billion investment into its manufacturing facilities in Indiana, a key anchor of its domestic manufact...

If you're looking for exposure to the anti-obesity drug market, you essentially have just two choices: You can chase smaller biotech stocks that might develop t...

Key Points Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before. Analysts have questioned whether Novo c...

Technology Novo Nordisk Pops As Wegovy Pill Doubles Sales Expectations In Its First Quarter Licensing Novo Nordisk (NVO) stock bounded higher early Wednesday af...

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...